792 filings
Page 6 of 40
DEFA14A
TGTX
TG Therapeutics Inc
30 Apr 21
Additional proxy soliciting materials
4:03pm
DEF 14A
TGTX
TG Therapeutics Inc
Definitive proxy
30 Apr 21
4:01pm
PRE 14A
TGTX
TG Therapeutics Inc
Preliminary proxy
20 Apr 21
5:00pm
8-K
TGTX
TG Therapeutics Inc
16 Apr 21
Other Events
7:53am
8-K
TGTX
TG Therapeutics Inc
13 Apr 21
Changes in Registrant's Certifying Accountant
4:30pm
8-K
TGTX
TG Therapeutics Inc
2 Mar 21
TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2020 Financial Results
7:07am
10-K
2020 FY
TGTX
TG Therapeutics Inc
Annual report
1 Mar 21
4:02pm
SC 13G/A
Great Point Partners LLC
16 Feb 21
TG THERAPEUTICS / GREAT POINT PARTNERS ownership change
12:00am
5
Power Sean A
12 Feb 21
TG THERAPEUTICS / Sean A Power ownership change
5:01pm
SC 13G/A
Ra Capital Management, LLC
10 Feb 21
TG THERAPEUTICS / RA CAPITAL MANAGEMENT ownership change
4:49pm
SC 13G/A
Ra Capital Management, LLC
10 Feb 21
TG THERAPEUTICS / RA CAPITAL MANAGEMENT ownership change
4:34pm
SC 13G
TGTX
TG Therapeutics Inc
10 Feb 21
TG THERAPEUTICS / VANGUARD ownership change
11:57am
SC 13G/A
TGTX
TG Therapeutics Inc
8 Feb 21
TG THERAPEUTICS / FMR ownership change
10:33am
8-K
TGTX
TG Therapeutics Inc
8 Feb 21
UKONIQ is approved for adult patients with relapsed or refractory marginal zone lymphoma after at least one prior anti-CD20 based regimen
7:01am
SC 13G/A
BLK
Blackrock Inc.
1 Feb 21
TG THERAPEUTICS / BlackRock ownership change
8:30am
4
Power Sean A
4 Jan 21
TG THERAPEUTICS / Sean A Power ownership change
4:30pm
5
Weiss Michael S
31 Dec 20
TG THERAPEUTICS / MICHAEL S WEISS ownership change
4:30pm
8-K
TGTX
TG Therapeutics Inc
16 Dec 20
Entry into a Material Definitive Agreement
4:16pm
424B5
TGTX
TG Therapeutics Inc
16 Dec 20
Prospectus supplement for primary offering
4:11pm
424B5
TGTX
TG Therapeutics Inc
14 Dec 20
Prospectus supplement for primary offering
8:09am